Related Experiment Video

Updated: Jun 23, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

[Transcatheter replacement of the aortic valve--a novel treatment modality for high-risk patients]

Lene Kjaer Olsen1, Thomas Engstrøm, Kristian Wachtell

  • 1Kardiologisk Klinik B 2014, Rigshospitalet, DK-2100 København Ø.

Ugeskrift for Laeger
|May 7, 2009
PubMed

Insights

Transcatheter aortic valve replacement offers a new treatment option for patients with aortic stenosis who are too high-risk for traditional surgery. This minimally invasive procedure is becoming increasingly important for managing this common valve disease.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Context:

  • Aortic stenosis is the most prevalent heart valve disease, with increasing prevalence due to rising life expectancy.
  • A significant portion of patients with aortic stenosis are inoperable for conventional surgical aortic valve replacement due to advanced age and comorbidities.
  • This demographic represents a growing clinical challenge in cardiovascular medicine.

Purpose:

  • To describe the transcatheter aortic valve replacement (TAVR) procedure.
  • To present current experiences and outcomes with TAVR in inoperable patients.
  • To highlight TAVR as an alternative treatment for high-risk aortic stenosis patients.

Summary:

  • Transcatheter aortic valve replacement (TAVR) is an alternative treatment for patients with severe aortic stenosis who are unsuitable for traditional open-heart surgery.
  • The procedure involves replacing the aortic valve via a catheter, offering a less invasive approach.
  • Current data indicate TAVR provides a viable option for managing this complex patient group.

Impact:

  • TAVR expands treatment options for inoperable patients with aortic stenosis, improving quality of life and potentially reducing mortality.
  • This minimally invasive technique addresses a critical unmet need in cardiovascular care.
  • The growing adoption of TAVR signifies a shift towards less invasive interventions in valvular heart disease management.

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...